13F filer · CIK 19617 ↗
Jpmorgan Chase & Co
You are looking at Q2 2019. See the latest, Q2 2026 →
Reported value
$511.43B
+4.5% on the quarter before
Positions
5,836
538 new · 500 sold out
Top 10
16.3%
of the value
Est. gain
+$11.71B
on stocks held all quarter
Est. return
+2.9%
on those stocks since Q1 2019
Positions as of Jun 30, 2019, from Jpmorgan Chase & Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 26% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2019. Striped tiles are options.
Largest buys
Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrPUT~$4.16BAdded · 0.7% → 1.5%+14,267,600 underlying
- Ishares Tr~$3.85BAdded · 0.0% → 0.8%+34,817,690 shares
- Ishares Tr~$1.53BAdded · 0.3% → 0.6%+13,731,291 shares
- Jp Morgan Exchange Traded Fd~$1.22BAdded · 0.5% → 0.7%+49,508,749 shares
- Chevron Corp New~$1.10BAdded · 0.5% → 0.7%+8,905,567 shares
- Jp Morgan Exchange Traded Fd~$984.9MAdded · 0.6% → 0.8%+41,123,781 shares
- Invesco Qqq TrPUT~$949.7MAdded · 0.4% → 0.6%+5,092,200 underlying
- Dupont De Nemours Inc~$826.8MNew · 0.0% → 0.2%+11,198,554 shares
- Meta~$765.0MAdded · 0.3% → 0.5%+4,037,012 shares
- Alibaba~$663.1MAdded · 0.7% → 0.8%+3,879,896 shares
Largest sells
Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr~$3.64BCut · 0.8% → 0.1%−42,919,680 shares
- Dowdupont Inc~$1.66BSold out · 0.3% → 0.0%−31,145,482 shares
- Occidental Pete Corp~$1.20BCut · 0.4% → 0.0%−24,136,243 shares
- ApplePUT~$984.0MCut · 0.3% → 0.1%−4,926,600 underlying
- Merck & Co Inc~$953.9MCut · 0.9% → 0.7%−11,378,892 shares
- Ishares IncCALL~$863.9MCut · 0.2% → 0.0%−19,772,500 underlying
- Visa Inc.~$838.1MCut · 0.6% → 0.5%−4,894,400 shares
- AT&T~$800.7MCut · 0.2% → 0.1%−24,279,155 shares
- Vanguard World Fds~$754.5MCut · 0.2% → 0.1%−3,584,793 shares
- Autozone Inc~$718.9MCut · 0.4% → 0.2%−663,133 shares
Holdings
As of Jun 30, 2019. Changes are in shares against Mar 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrFUND · shares −0.6% · price +3.2% | 5.0% | $25.43B | +$786.9M | ||||||||
| MicrosoftCOMMON · shares +3.5% · price +13.7% | 2.5% | $12.73B | +$1.49B | ||||||||
| AmazonCOMMON · shares +1.8% · price +6.9% | 1.6% | $8.21B | +$523.2M | ||||||||
| SPDR S&P 500 ETF TrPUTOPTION · shares +113% | 1.5% | $7.83B | — | ||||||||
| AppleCOMMON · shares −5.1% · price +5.2% | 1.2% | $6.37B | +$312.1M | ||||||||
| Ishares TrFUND · shares −3.9% · price +0.8% | 1.1% | $5.64B | +$43.1M | ||||||||
| Pfizer IncCOMMON · shares +5.1% · price +2.3% | 0.93% | $4.77B | +$100.2M | ||||||||
| Vanguard Charlotte FdsFUND · shares +7.2% · price +2.7% | 0.84% | $4.28B | +$103.1M | ||||||||
| AlphabetCOMMON · shares −3.1% · price −8.3% | 0.79% | $4.04B | −$365.6M | ||||||||
| AlibabaADR · shares +20% · price −6.3% | 0.79% | $4.04B | −$228.3M | ||||||||
| Jp Morgan Exchange Traded FdFUND · shares +32% · price +1.6% | 0.79% | $4.04B | +$47.1M | ||||||||
| Ishares TrFUND · shares +7,027% · price +0.1% | 0.76% | $3.91B | +$49,324 | ||||||||
| Bank Amer CorpCOMMON · shares −5.9% · price +2.2% | 0.75% | $3.84B | +$84.3M | ||||||||
| AlphabetCOMMON · shares +9.1% · price −8.5% | 0.72% | $3.69B | −$315.3M | ||||||||
| MastercardCOMMON · shares +12% · price +10.9% | 0.71% | $3.64B | +$317.9M | ||||||||
| Chevron Corp NewCOMMON · shares +44% · price −0.1% | 0.70% | $3.60B | −$1.4M | ||||||||
| Jp Morgan Exchange Traded FdFUND · shares +52% · price +3.4% | 0.70% | $3.56B | +$77.6M | ||||||||
| Unitedhealth Group IncCOMMON · shares −7.0% · price −0.4% | 0.69% | $3.52B | −$13.1M | ||||||||
| Texas InstrumentsCOMMON · shares +1.2% · price +9.2% | 0.68% | $3.48B | +$290.5M | ||||||||
| Merck & Co IncCOMMON · shares −22% · price +0.8% | 0.66% | $3.39B | +$26.7M | ||||||||
| Jp Morgan Exchange Traded FdFUND · shares +5.0% · price +0.0% | 0.64% | $3.26B | +$611.46 | ||||||||
| Coca Cola CoCOMMON · shares +2.8% · price +9.0% | 0.62% | $3.19B | +$256.5M | ||||||||
| Invesco Qqq TrPUTOPTION · shares +43% | 0.61% | $3.14B | — | ||||||||
| Home Depot IncCOMMON · shares −1.3% · price +7.9% | 0.61% | $3.11B | +$227.3M | ||||||||
| Johnson & JohnsonCOMMON · shares +15% · price +0.6% | 0.60% | $3.07B | +$17.2M | ||||||||
| Total · 5,836 positions | 100% | $511.43B | +$11.71B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2019 to Q2 2019: 4,346 stocks held throughout, up $11.71B (+2.9%).
- Microsoft+$1.49B+14%
- SPDR S&P 500 ETF Tr+$786.9M+3%
- Amazon+$523.2M+7%
- Mastercard+$317.9M+11%
- Apple+$312.1M+5%
- Philip Morris Intl Inc−$163.3M−12%
- Alibaba−$228.3M−6%
- Eli Lilly−$306.4M−14%
- Alphabet−$315.3M−9%
- Alphabet−$365.6M−8%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 15 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.81T+16% | SEC ↗ |
| Q1 2026 | May 13, 2026 (amended) | $1.56T−2% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $1.59T−52% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 (amended) | $3.34T+118% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $1.53T+12% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.37T+2% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.34T−49% | SEC ↗ |
| Q3 2024 | Nov 8, 2024 (amended) | $2.63T+8% | SEC ↗ |
| Q2 2024 | Aug 12, 2024 (amended) | $2.44T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 (amended) | $2.37T+14% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $2.08T+130% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $906.36B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $920.27B+12% | SEC ↗ |
| Q1 2023 | May 18, 2023 (amended) | $820.88B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $758.55B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $696.38B−3% | SEC ↗ |
| Q2 2022 | Aug 11, 2022 | $717.86B−14% | SEC ↗ |
| Q1 2022 | May 11, 2022 | $830.28B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 (amended) | $865.90B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $808.68B−4% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $838.21B+12% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $749.21B+10% | SEC ↗ |
| Q4 2020 | Feb 19, 2021 (amended) | $680.63B+14% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 (amended) | $595.09B+15% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $518.17B+22% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $425.90B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $536.28B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $502.15B−2% | SEC ↗ |
| Q2 2019 | Aug 7, 2019 | $511.43B+4% | SEC ↗ |
| Q1 2019 | May 7, 2019 | $489.55B+13% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 | $432.49B−17% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 (amended) | $522.20B+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $486.35B+4% | SEC ↗ |
| Q1 2018 | May 10, 2018 | $466.55B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $474.64B+5% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $453.26B+4% | SEC ↗ |
| Q2 2017 | Aug 9, 2017 | $437.53B−0% | SEC ↗ |
| Q1 2017 | May 10, 2017 | $437.58B+5% | SEC ↗ |
| Q4 2016 | Feb 6, 2017 | $416.17B+2% | SEC ↗ |
| Q3 2016 | Nov 4, 2016 | $406.33B+1% | SEC ↗ |
| Q2 2016 | Aug 8, 2016 | $401.04B+3% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $390.67B | SEC ↗ |